Yahoo Finance Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
"I’ve become successful at blending in. ... But I’ve also experienced moments of deep loneliness."
Liv Rose, 25, started struggling with stomach pain when she was a child but has now been diagnosed with gastroparesis.
Enbridge (TSX:ENB) stock has barely moved in the last few years, with ongoing issues. But there are still reasons that could make it work for investors. The post 3 Reasons to Buy Enbridge Stock Like There’s No Tomorrow appeared first on The Motley Fool Canada.
Do you have some extra cash to spare? These three discounted stocks are poised for a rebound. The post 3 Beaten-Down Stocks that Could Take Off in the New Bull Market appeared first on The Motley Fool Canada.
These two dividend stocks don't just offer a nice dividend, but huge growth. With one potentially being a major winner in 2024. The post 2 Dividend Stocks to Double up on Right Now appeared first on The Motley Fool Canada.
(Bloomberg) -- The cocoa market was whipsawed by extreme volatility in the futures market on Tuesday amid a lack of liquidity.Most Read from BloombergHSBC CEO Quinn Unexpectedly Steps Down After Almost 5 YearsBinance and CZ’s Fortunes Are Set to Grow, Even in JailWall Street Hit by Fed Jitters to Close Wild April: Markets WrapTesla Soars on Tentative China Approval for Driving SystemStocks Trade for 390 Minutes a Day. Increasingly, Only 10 MatterAfter more than doubling this year, futures traded
A Canadian expert weighed in on the highly contagious bug causing vomiting and diarrhea.
Ticks don't care if there's snow on the ground, so here's why Canadians should be cautious.
Too wide a spread between interest rates here and in the U.S. could hurt the Canadian dollar and reignite inflation
For most people approaching or in their golden years, supplements can be a boon.
Charles candidly described the experience of being told he had the disease.
Shopify stock was climbing Monday after an analyst upgraded shares of the e-commerce platform on confidence in growth. Citi analyst Tyler Radke upgraded shares of Shopify to Buy from Neutral, and increased his target price to $105 from $93, which implies a 47% increase in the stock price as of Friday’s close. “Our Deep-Dive analysis into SHOP’s Merchant Solutions business gives us confidence in SHOP’s long-term growth,” Radke wrote in a research note.
"We expect, in any case, that the Fed's communications after the FOMC meeting this week will have a uniformly hawkish tone," Macquarie said.
Moderate drinking was once thought to have benefits for the heart. But better research methods have thrown cold water on that idea. A growing number of public health experts say if you choose to drink alcohol, you should drink as little as possible. (AP Video: Laura Bargfeld)
The King connected with cancer patients, telling them, "It's always a bit of shock when they tell you"
Investing in high-yield dividend stocks such as Diversified Royalty can help you begin a stable stream of recurring income. The post This 9% Dividend Stock Pays Cash Every Month appeared first on The Motley Fool Canada.
“I guess just a PSA to investors out there: You only get eventual justice with the SEC, if you even get that,” Asana CEO Dustin Moskovitz said.
A Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine nearly three years ago says he's still suffering despite seeking medical help both in Canada and abroad."There is no improvement at all," said Tisir Otahbachi. "I feel itchy and burning, all [over] my body."Otahbachi, 30, has now applied for financial relief under Quebec's vaccine injury support program but has heard nothing from its administrators since they acknowledged receipt of his application
There are five major events to watch for this week, highlighted by a Fed meeting and the April jobs report.
Artificial intelligence stocks have been on a roll for the past few months, mostly driving the market rally. Nvidia delivered record-breaking earnings on Feb. 21, with revenue rising to a staggering...